From Science to Finance—A Tool for Deriving Economic Implications from the Results of Dietary Supplement Clinical Studies

REFERENCES

• Agency for Healthcare Research and Quality. (2010). Medical Expenditure Panel Survey (MEPS). Retrieved February 2013, Available from http://meps.ahrq.gov/mepsweb/
   Google Scholar
• Albert C, Cook N, Gaziano J, Zaharris E, MacFadyen J, Danielson E, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA, 2008;299(17):2027–36.
   PubMed Web of Science ®Google Scholar
• American Public Health Association—Center for Public Health Policy. (2012). The Prevention and Public Health Fund: A critical investment in our nation's physical and fiscal health. Retrieved March 2013, Available from http://www.apha.org/NR/rdonlyres/8FA13774-AA47-43F2–838B-1B0757D111C6/0/APHA_PrevFundBrief_June2012.pdf
   Google Scholar
• Brouwer I, Zock P, Camm A, Böcker D, Hauer R, & Wever E, et al. SOFA Study Group—Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fattyand Ventricular Arrhythmia (SOFA) randomized trial. JAMA, 2006;295(22):2613–9.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2013). Heart Disease Facts. Retrieved March 1, 2013, Available from http://www.cdc.gov/heartdisease/facts.htm
   Google Scholar
• Centers for Disease Control and Prevention. (n.d.). The power to prevent, the call to control: At a glance 2009. Retrieved March 2013, from Chronic Disease Prevention and Health Promotion: Available from http://www.cdc.gov/chronicdisease/resources/publications/aag/chronic.htm
   Google Scholar
• Cleveland Clinic. (2011). Heart and Vascular Health & Prevention. Retrieved March 2013, Available from http://my.clevelandclinic.org/heart/prevention/nutrition/phytosterols-sterols-stanols.aspx
   Google Scholar
• Cohen JT, Neumann PJ, & Weinstein MC.. Does preventive care save money? Health economics and the presidential candidates. N Engl J Med, 2008;358(7):661–3.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, & Kacker R. Random-effects model for meta-analysis of clinical trials—An update. Contemporary Clinical Trials, 2007;28(2):105–14.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, & Laird N. Literature Review in clinical trials. Control Clinical Trials, 1986;7(3):177–88.
   PubMedGoogle Scholar
• Division for Heart Disease and Stroke Prevention. (2013). Division for Heart Disease and Stroke Prevention—Centers for Disease Control and Prevention. Retrieved March 2013, from Division for Heart Disease and Stroke Prevention: Available from http://www.cdc.gov/dhdsp/
   Google Scholar
• Galan P, de Bree A, Mennen L, Potier de Courcy G, Preziozi P, & Bertrais S, et al. Background and rationale of the SU.FOL.OM3 study: double-blind randomized placebo-controlled secondary prevention trial to test the impact of supplementation with folate, vitamin B6 and B12 and/or omega-3 fatty acids on the prevention of recurrent ischemi. J Nutr Health Aging, 2003;7(6):428–35.
   PubMedGoogle Scholar
• Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, & Hercberg S. SU.FOL.OM3 Collaborative Group. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ, 2010;341:c6273.
   PubMed Web of Science ®Google Scholar
• Hankey G, Ford A, Yi Q, Eikelboom J, Lees K, & Chen C, et al. VITATOPS Trial Study Group: B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol, 2010;9(9):855–65.
   PubMed Web of Science ®Google Scholar
• Harvard School of Public Health Nutrition Source. (2013). Three of the B Vitamins: Folate, Vitamin B6, and Vitamin B12. Retrieved March 2013, Available from http://www.hsph.harvard.edu/nutritionsource/vitamin-b/
   Google Scholar
• Institute of Medicine. (1998). Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline. Washington, D.C.: National Academy Press.
   Google Scholar
• Institute of Medicine. (2006). Dietary Reference Intakes: The Essential Guide to Nutrient Requirements. Washington, D.C.: National Academies Press.
   Google Scholar
• Ipsos Public Affairs. (2012). 2012 Council for Responsible Nutrition Consumer Survey on Dietary Supplements. Ipsos Public Affairs. Paris, France.
   Google Scholar
• Kris-Etherton P, Harris W, & Appel L. Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation, 2002;106:2747–2757.
   PubMed Web of Science ®Google Scholar
• Leaf A. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids.. Fundam Clin Pharmacol, 2006;20(6):525–38.
   PubMed Web of Science ®Google Scholar
• Lonn E, Yusuf S, Arnold M, Sheridan P, Pogue J, & Micks M, et al. Heart Outcomes Prevention Evaluation (HOPE) 2 Investigators. Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med, 2006;354(15):1567–77.
   PubMed Web of Science ®Google Scholar
• Marchioli R. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infactions: results of the GISSI-Prevenzione trial. Lancet, 1999;354(8):447–455.
   PubMedGoogle Scholar
• Memorial Sloan-Kettering Cancer Center. (2013). About Herbs, Botanicals & Other Products—Intergrative Medicine. Retrieved February 2013, Available from http://www. mskcc.org/cancer-care/integrative-medicine/about-herbs-botanicals-other-products
   Google Scholar
• National Health and Nutrition Examination Survey. (2010). National Health and Nutrition Examination Survey. Retrieved March 2013, from Centers for Disease Control and Prevention: Available from http://www.cdc.gov/nchs/nhanes.htm
   Google Scholar
• National Institutes of Health. (2012). National Heart, Lung, and Blood Institute—Department of Health and Human Services. Retrieved March 2013, from What Is Coronary Heart Disease: Available from http://www.nhlbi.nih.gov/health/health-topics/topics/cad/
   Google Scholar
• Raitt M, Connor W, Morris C, Kron J, Halperin B, & Chugh S, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA, 2005;293(23):2884–91.
   PubMed Web of Science ®Google Scholar
• Roncaglioni M, Tombesi M, Avanzini F, Barlera S, Caimi V, & Longoni P, et al. n-3 Fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med, 2013;368(19):1800–8.
   PubMed Web of Science ®Google Scholar
• Russell LB. (2007). Prevention's Potential for Slowing the Growth of Medical Spending. Retrieved March 2013, Available from http://www.ihhcpar.rutgers.edu/ downloads/RussellNCHC2007.pdf
   Google Scholar
• Schnyder G, Roffi M, Flammer Y, Pin R, & Hess O. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA, 2002;288(8):973–9.
   PubMed Web of Science ®Google Scholar
• Shanahan C. & de Lorimier R. (2013). Smart Prevention—Health Care Cost Savings Resulting from the Targeted Use of Dietary Supplement. An Economic Case for Promoting Increased Intake of Key Dietary Supplements as a Means to Combat Unsustainable Health Care Cost Growth in the United State. Frost & Sullivan. Available from http://www.frost.com/sublib/display-market-insight.do?id=285115104
   Google Scholar
• Svensson M, Schmidt E, Jørgensen K, & Christensen J. OPACH Study Group. N-3 fatty acids as secondary prevention against cardiovascular events in patients who undergo chronic hemodialysis: a randomized, placebo-controlled intervention trial. Clin J Am Soc Nephrol, 2006;1(4):780–6.
   PubMed Web of Science ®Google Scholar
• Tavazzi L. GISSI-HF Investigators. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomized, double-blind, placebo-controlled trial. Lancet, 2008;372(10):1223–1230.
   PubMedGoogle Scholar
• Toole J, Malinow M, Chambless L, Spence J, Pettigrew L, & Howard V, et al. Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA, 2004;291(5):565–75.
   PubMed Web of Science ®Google Scholar
• U.S. Food & Drug Administration. (2012). CFR—Code of Federal Regulations Title 21. Retrieved March 2013, from http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfcfr/CFRSearch.cfm?fr=101.81
   Google Scholar
• U.S. Food and Drug Administration. (2013). Q&A on Dietary Supplements. Retrieved May 2013
   Google Scholar
• World Health Organization. (2008). WHO guide for standardization of economic evaluations of immunization programmes. Retrieved March 2013, from http://whqlibdoc.who.int/hq/2008/WHO_IVB_08.14_eng.pdf
   Google Scholar
• Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, & Ishikawa Y, et al. Japan EPA lipid intervention study (JELIS) Investigators. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomized open-label, blinded endpoint analysis. Lancet, 2007;369(9567):1090–8.
   PubMed Web of Science ®Google Scholar